Prostate Cancer UK Professionals

@prostateukprofs

Here we share news and views from @ProstateCancerUK for our growing professional community who have an interest in prostate disease 🧑‍🔬⤵️

445 Following321 Followers392 Posts

Bluesky

Is this your profile?Claim it and prostateukprofs.dirty.social is yours.Claim profile

Prostate Cancer UK Professionals@prostateukprofs· 7d

Working in prostate cancer care? Follow our new LinkedIn page for clinical updates, guidance, education & CPD, practical tools and patient info. Join a dedicated space for healthcare professionals to stay informed, connected and supported. buff.ly/GeYu30f #ProstateCancer #HealthProfessionals

Person with white beard resting chin on hand while looking at a laptop, wearing a black shirt with small crown and human-figure lapel pins and a wristband.

Prostate Cancer UK Professionals@prostateukprofs· 20d

📣 Urologists needed to help reduce overtreatment of prostate cancer Help refine an e-learning resource to support discussions about active surveillance and treatments for localised prostate cancer. 90–120 min online focus group. Get involved ➡️ buff.ly/bhnFb7Z

A middle-aged black man receiving comforting support from a younger relative while they consult a nurse and a doctor in a clinic, holding a health leaflet and discussing his care.

Prostate Cancer UK Professionals@prostateukprofs· 27d

Prostate Cancer UK grants of £500–£10,000 are available for projects raising awareness of prostate cancer among Black men. ➡️ Please share with eligible charities, CICs or CIOs 🕐️ Applications close on 31 July 2026 ✉️ Email bheinbox@prostatecanceruk.org to find out more

Call for organisations serving Black communities to apply for Prostate Cancer UK community grants to fund awareness, events, culturally tailored engagement and early-diagnosis outreach; grants £500–£5,000 (larger £5,000–£10,000); applications 1–31 Jul 2026; shows smiling Black men.

Prostate Cancer UK Professionals@prostateukprofs· 28d

Boost your clinical confidence in #prostatecancer care with free, bite-sized e-learning modules authored by radiotherapy and oncology expert Catherine Holborn. These interactive, evidence-based courses align with current guidelines and count towards your self-accredited #CPD. buff.ly/KaQlTRU

Man sitting on a couch in a living room reading an online course titled "Prostate Cancer Essentials: Part 2 – Diagnosing And Staging" on a laptop, suggesting he’s studying health information at home.

Prostate Cancer UK Professionals@prostateukprofs· Jun 30

📢 Prostate cancer specialists wanted Help refine an e-learning resource to support clinician–patient discussions and informed decision-making about active surveillance and treatment options for low/intermediate-risk prostate cancer. 90–120 min online focus group + £60. Register: buff.ly/qa3Cocf

Prostate Cancer UK Professionals@prostateukprofs· Jun 22

We're here to support anyone affected by prostate cancer - whether they need information about a diagnosis, someone who's had treatment to talk to, or help with side effects. We'll cover our support services in this webinar. 📅 24 June 🕕️ 6pm–7.30pm Signpost to patients: buff.ly/Cqxxr1W

Prostate Cancer UK Professionals@prostateukprofs· Jun 22

From the 29th June, The Patients Association will be hosting free webinars as part of Patient Partnership Week. This will bring together patients, professionals, policymakers, and researchers to explore what meaningful partnership looks like in practice. More information here ➡️ buff.ly/TLwgPdU

Prostate Cancer UK Professionals@prostateukprofs· Jun 5

What do the latest UK NSC recommendation on prostate cancer screening and TRANSFORM trial expansion mean for practice? Read our summary for health professionals, access FAQs and share your feedback: buff.ly/U2UnXx3

Prostate Cancer UK Professionals@prostateukprofs· Jun 4

Please share with patients our free webinar. Our upcoming webinar will help men feel less alone and more supported after a prostate cancer diagnosis, with information about our services available and insight from others with lived experience. 📅 24 June 🕕 6pm–7:30pm Details here: buff.ly/cX658LF

Prostate Cancer UK Professionals@prostateukprofs· May 28

Dr Alan McWilliam @manchester.ac.uk leads a #research team working to make #radiotherapy treatment more precise. Since 2021, we’ve supported his team to develop a way to more quickly identify men with #ProstateCancer who are not responding to treatment. 📙 Read more: buff.ly/fQjCGRM

Dr Alan McWilliam quote: This research could help make radiotherapy treatment more personalised by identifying those at risk of their cancer returning, while reducing side effects and improving quality of life.

Prostate Cancer UK Professionals@prostateukprofs· May 27

NICE is recruiting a professional member for the Prostate Cancer: Diagnosis & Management committee. If you’re a health or social care professional with relevant expertise, this is a great chance to influence national guidance and improve patient outcomes. Read more & apply ➡️ buff.ly/qwyLij3

Prostate Cancer UK Professionals@prostateukprofs· May 26

Macmillan and @rc-pharm.bsky.social are seeking healthcare professionals’ views on managing medicines and polypharmacy during cancer care. Your insights will help improve medicines optimisation, patient support and care for people affected by cancer. Take the survey ➡️ buff.ly/yIrGMoV

Picture shows different colour pill/medicine packets

Prostate Cancer UK Professionals@prostateukprofs· May 21

Professor Val Macaulay @ndsurgicalsci.bsky.social led a research group investigating the role of IGF‑1 in #ProstateCancer. Since 2004, we’ve supported her team to explore whether drugs targeting IGF‑1 could help slow the growth of localised prostate cancer. 📙 Read more: buff.ly/GyaDLdr

Professor Val Macaulay quote: We hope our research will help uncover how IGF-1 drives prostate cancer growth and provide evidence that early cancers can be stopped from progressing.

Prostate Cancer UK Professionals@prostateukprofs· May 19

Could measuring ctDNA & serum PSA identify men with advanced #ProstateCancer who may benefit from treatment intensification? A team @ucl.ac.uk & the University of Trento, led by Profs Francesca Demichelis & Gert Attard, publish findings in @natcancer.nature.com. Grab a ☕ & read: lnkd.in/eeSkYZVX

Scientific Paper published in Nature Cancer, titled: Combined ctDNA and serum PSA for dynamic monitoring of metastatic prostate cancer starting first-line treatment: a prospective national cohort study. Written by Jayaram et al.

Prostate Cancer UK Professionals@prostateukprofs· May 14

Dr Robert Kypta at @imperialcollegeldn.bsky.social leads a team exploring novel treatments for #ProstateCancer. Since 2022, we’ve supported his team to develop a new targeted drug delivery approach, helping protect healthy cells and reduce side effects. Read more 📙: bit.ly/4u2x383

Prostate Cancer UK Professionals@prostateukprofs· May 8

📢 Introducing Dr Shaun Scaramuzza, the first of our 2025 Career Acceleration Fellows! 🔬 Shaun’s research aims to improve early detection and treatment options for men at highest risk. Our 2026 round is still open for applications! You can apply here: buff.ly/3fXLLUz

Prostate Cancer UK Professionals@prostateukprofs· May 7

Dr Susan Heavey at @ucl.ac.uk leads a team focused on making drug development more effective. Since 2018, we’ve supported her team to use patient‑derived explants & spatial transcriptomics to identify the most promising #ProstateCancer treatments. 📙 Read more: bit.ly/2ADGYs9

Prostate Cancer UK Professionals@prostateukprofs· May 5

Could PSA levels measured during & after treatment, together with radiological features, help guide personalised treatment decisions for men with #ProstateCancer? A team led by Prof Gert Attard @ucl.ac.uk share new findings in @thelancetoncol.bsky.social. Grab a ☕️ & read: doi.org/10.1016/S147...

Scientific Paper published in The Lancet Oncology, titled: On-treatment serum prostate-specific antigen and overall survival in prostate cancer (STAMPEDE platform protocol): a post-hoc analysis of data from five phase 3 trials. Written by Kayani et al.

Prostate Cancer UK Professionals@prostateukprofs· Apr 29

Strengthening the UK #prostatecancer clinical research pipeline.🔬 Our April in person CRSG meeting sparked rich discussion on major research proposals & UK wide collaboration. Huge thanks to our proposal presenters, CRSG and Early Career members. 👏 📙https://bit.ly/4mGKnfK

Prostate Cancer UK Professionals@prostateukprofs· Apr 28

How have the PACE trials influenced radiotherapy treatment for #ProstateCancer? Profs Nicholas van As & @profemmahall.bsky.social @icr.ac.uk share learnings from a decade of trials, including Prostate Cancer UK-funded PACE-NODES, in @ijrobp.bsky.social. Grab a ☕ & read: doi.org/10.1016/j.ij...

Scientific Paper titled: The PACE Trials: A Decade of Progress and the Lessons Learned. Written by van As et al.

Prostate Cancer UK Professionals@prostateukprofs· Apr 27

The April edition of Research News is here! Read about: 💙 The TRANFORM screening trial. 📢 Our new LinkedIn channel for prostate cancer researchers. 🔬 Research stories with impact. 🏆 Researcher achievements. 💰 Funding opportunities. Read it here 📰 : buff.ly/k09eMvo

Prostate Cancer UK Professionals@prostateukprofs· Apr 24

Prostate Cancer UK funded a team led by Prof Noel Clarke at the Movember FASTMAN Centre of Excellence to analyse bone scans from the STAMPEDE trial. They explored whether adding radiotherapy to the prostate could help men whose cancer had spread. 📙 prostatecanceruk.org/research/res...

Prostate Cancer UK Professionals@prostateukprofs· Apr 23

🥼 Professor Simon Mackay @unistrathclyde.bsky.social leads a team developing new treatments for men with advanced #ProstateCancer. 💊 In 2019, we funded Simon to further develop his first-in-class IKKα inhibitor. 📙 Read more about Simon's innovative #research: prostatecanceruk.org/research/res...

Graphic with a man icon holding a sign reading 'Research We Fund' on the left hand side, a portrait photo of Professor Simon Mackay in the top right corner, and a quote from Simon reading 'Thanks to the funding from Prostate Cancer UK, we have brought this treatment one step closer to clinical trials. After all this time, I'd be over the moon if I could make that difference to men affected by prostate cancer'.

Prostate Cancer UK Professionals@prostateukprofs· Apr 22

📣 Job Opportunity: Biobank Manager for TRANSFORM Discovery. Play a central role in developing a world-leading high-quality data & tissue resource and help TRANSFORM outcomes for men affected by #ProstateCancer. Full details ⤵️ www.imperial.ac.uk/jobs/search-...

Prostate Cancer UK Professionals@prostateukprofs· Apr 21

Could hypoxia and angiogenesis gene expression help personalise #ProstateCancer radiotherapy? Funded by our Movember FASTMAN Centre of Excellence, Prof Hoskin and Prof Choudhury @christieinstitute.bsky.social share new findings in Clinical Oncology. Grab a ☕ and read: bit.ly/4sHE25b

Graphic of a recently published research article, titled 'Predicting high-dose-rate brachytherapy boost benefit using hypoxia and angiogenesis gene expression in localised prostate cancer' by Lodhi et al.

Prostate Cancer UK Professionals@prostateukprofs· Apr 16

Our final Patient Research Partner speech comes from Patrick. Diagnosed with Stage 4 #ProstateCancer in 2020, Patrick is dedicated to raising awareness, visiting many organisations and businesses. A huge thank you to all of our inspirational Patient Research Partners 👏

Prostate Cancer UK Professionals@prostateukprofs· Apr 16

It’s time for the final session of From Ideas to Innovation 2026 🗣️ The focus is on advanced #ProstateCancer, and we’re delighted to be joined by speakers Professor Gerhardt Attard, Dr Ashwin Sachdeva and Dr Emily Grist.

Prostate Cancer UK Professionals@prostateukprofs· Apr 16

Kicking off the first session of the afternoon 🎤 Simon and Hayley from our research team are sharing how @prostatecanceruk.bsky.social can support researchers - from making key introductions, to our open access reimbursement scheme, to helping their work reach the audiences that matter.

Prostate Cancer UK Professionals@prostateukprofs· Apr 16

Derek’s father died from oligometastatic #ProstateCancer, before Derek was diagnosed with the disease himself some years later. After his surgery, Derek began volunteering for @prostatecanceruk.bsky.social and served as a patient representative on our research committees for over 10 years.

Prostate Cancer UK Professionals@prostateukprofs· Apr 16

Next up is a session on primary and metastatic cancer. Great to welcome Professor Charlotte Bevan and PhD student Nuria Fortuno from Imperial College London (@IP-London.bsky.social). ➡️ Find out more about their work: bit.ly/46Bqsal